ATE428413T1 - NEW USE OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF CENTRAL NEUROPATHIC PAIN - Google Patents
NEW USE OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF CENTRAL NEUROPATHIC PAINInfo
- Publication number
- ATE428413T1 ATE428413T1 AT04803465T AT04803465T ATE428413T1 AT E428413 T1 ATE428413 T1 AT E428413T1 AT 04803465 T AT04803465 T AT 04803465T AT 04803465 T AT04803465 T AT 04803465T AT E428413 T1 ATE428413 T1 AT E428413T1
- Authority
- AT
- Austria
- Prior art keywords
- neuropathic pain
- treatment
- peptide compounds
- new use
- central neuropathic
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 208000004296 neuralgia Diseases 0.000 title abstract 2
- 208000021722 neuropathic pain Diseases 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Abstract
The present invention concerns the use of compounds for treating central neuropathic pain.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03027742A EP1537862A1 (en) | 2003-12-02 | 2003-12-02 | Novel use of peptide compounds for treating central neuropathic pain |
US53089503P | 2003-12-22 | 2003-12-22 | |
EP03029632 | 2003-12-22 | ||
PCT/EP2004/013729 WO2005053667A1 (en) | 2003-12-02 | 2004-12-02 | Novel use of peptide compounds for treating central neuropathic pain |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE428413T1 true ATE428413T1 (en) | 2009-05-15 |
Family
ID=34657533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04803465T ATE428413T1 (en) | 2003-12-02 | 2004-12-02 | NEW USE OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF CENTRAL NEUROPATHIC PAIN |
Country Status (17)
Country | Link |
---|---|
US (1) | US7794987B2 (en) |
EP (1) | EP1689378B1 (en) |
JP (1) | JP4664924B2 (en) |
KR (1) | KR20060111524A (en) |
AT (1) | ATE428413T1 (en) |
AU (1) | AU2004294714B2 (en) |
BR (1) | BRPI0417101A (en) |
CA (1) | CA2545543A1 (en) |
DE (1) | DE602004020657D1 (en) |
EA (1) | EA013590B1 (en) |
ES (1) | ES2325995T3 (en) |
HK (1) | HK1095749A1 (en) |
IL (1) | IL175770A0 (en) |
NO (1) | NO20063064L (en) |
NZ (1) | NZ546576A (en) |
PL (1) | PL1689378T3 (en) |
WO (1) | WO2005053667A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1243262T3 (en) | 2001-03-20 | 2006-10-02 | Sanol Arznei Schwarz Gmbh | Hitherto unknown use of a peptide class of compounds to treat non-neuropathic inflammatory pain |
ATE228358T1 (en) * | 2001-03-21 | 2002-12-15 | Sanol Arznei Schwarz Gmbh | NEW USE OF A CLASS OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF ALLODYNIA OR OTHER TYPES OF CHRONIC OR PHANTOMATIC PAIN |
JP4664924B2 (en) | 2003-12-02 | 2011-04-06 | ウーツェーベー ファルマ ゲーエムベーハー | Novel use of peptide compounds for the treatment of central neuropathic pain |
EP1579858A1 (en) * | 2004-03-26 | 2005-09-28 | Schwarz Pharma Ag | Novel use of peptide compounds for treating pain in painful diabetic neuropathy |
US20100256179A1 (en) * | 2004-03-26 | 2010-10-07 | Ucb Pharma Gmbh | Combination therapy for pain in painful diabetic neuropathy |
US20070042969A1 (en) * | 2004-03-26 | 2007-02-22 | Srz Properties, Inc. | Combination therapy for pain in painful diabetic neuropathy |
CN1950101B (en) * | 2004-04-16 | 2011-03-30 | 舒沃茨药物股份公司 | Use of peptidic compounds for the prophylaxis and treatment of chronic headache |
EP1604655A1 (en) * | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating pain in trigeminal neuralgia |
CA2573125A1 (en) * | 2004-08-27 | 2006-03-02 | Schwarz Pharma Ag | Novel use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain |
EP1642889A1 (en) * | 2004-10-02 | 2006-04-05 | Schwarz Pharma Ag | Improved synthesis scheme for lacosamide |
US20060252749A1 (en) * | 2005-01-28 | 2006-11-09 | Srz Properties, Inc. | Lacosamide for add-on therapy of psychosis |
US20070043120A1 (en) * | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
EP1754476A1 (en) * | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia |
US7902401B2 (en) | 2006-12-14 | 2011-03-08 | Nps Pharmaceuticals, Inc. | Fluorinated compounds |
ATE530175T1 (en) * | 2006-06-08 | 2011-11-15 | Ucb Pharma Gmbh | THERAPEUTIC COMBINATION FOR PAINFUL MEDICAL CONDITIONS |
EP1873527A1 (en) * | 2006-06-30 | 2008-01-02 | Schwarz Pharma Ag | Method for identifying CRMP modulators |
AR061476A1 (en) | 2006-06-15 | 2008-08-27 | Sanol Arznei Schwarz Gmbh | PHARMACEUTICAL COMPOSITION WITH SYNERGIC ANTI-CONVULSIVE EFFECT |
CN101466390B (en) | 2006-06-15 | 2014-03-12 | 优时比制药有限公司 | Pharmaceutical composition with synergistic anticonvulsant effect |
WO2008070994A1 (en) | 2006-12-14 | 2008-06-19 | Nps Pharmaceuticals, Inc. | Use of d-serine derivatives for the treatment of anxiety disorders |
EP2214657A1 (en) * | 2007-10-23 | 2010-08-11 | UCB Pharma GmbH | Compounds for treating demyelination conditions |
WO2009121483A1 (en) * | 2008-04-02 | 2009-10-08 | Sanofi-Aventis | Highly bridged peptides from actinomadura namibiensis |
EP2468261A1 (en) | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulation of lacosamide |
WO2012072256A2 (en) | 2010-12-02 | 2012-06-07 | Ucb Pharma Gmbh | Once daily formulation of lacosamide |
KR20210115502A (en) | 2020-03-13 | 2021-09-27 | (주)포에버엔케이 | Methods and Transdermal Injectable Composition for Pain Relief Containing Functional Peptide |
KR20230042193A (en) | 2021-09-19 | 2023-03-28 | (주)포에버엔케이 | Methods and Transdermal Injectable Composition for Pain Relief Containing Functional Peptide |
Family Cites Families (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378729A (en) * | 1985-02-15 | 1995-01-03 | Research Corporation Technologies, Inc. | Amino acid derivative anticonvulsant |
US5654301A (en) * | 1985-02-15 | 1997-08-05 | Research Corporation Technologies, Inc. | Amino acid derivative anticonvulsant |
EP0529680B1 (en) | 1987-08-01 | 1998-05-13 | Takeda Chemical Industries, Ltd. | Intermediates, their production and their use for preparing alpha-unsaturated amines |
US5962490A (en) * | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
YU47834B (en) | 1989-08-10 | 1996-01-09 | Schering Agrochemical Limited | THE AZOLE PESTICIDE |
TW217417B (en) | 1991-12-04 | 1993-12-11 | Manyu Seiyaku Kk | |
US5585358A (en) * | 1993-07-06 | 1996-12-17 | Yissum Research Development Corporation Of The Hebrew University Of Jerusalem | Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents |
GB9504854D0 (en) * | 1994-03-31 | 1995-04-26 | Zeneca Ltd | Nitrogen derivatives |
US5760038A (en) * | 1995-02-06 | 1998-06-02 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
US5849737A (en) * | 1995-04-14 | 1998-12-15 | The Regents Of The University Of California | Compositions and methods for treating pain |
JP4313435B2 (en) * | 1995-07-24 | 2009-08-12 | トラスティーズ オブ ボストン ユニバーシティー | Inhibition of NMDA receptor activity by pregnenolone sulfate derivatives |
US6114390A (en) * | 1995-11-30 | 2000-09-05 | Karl Thomae Gmbh | Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
DE19544687A1 (en) | 1995-11-30 | 1997-06-05 | Thomae Gmbh Dr K | Amino acid derivatives, medicaments containing these compounds and processes for their preparation |
US6037324A (en) * | 1996-01-04 | 2000-03-14 | Leukosite, Inc. | Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor |
GB9601724D0 (en) * | 1996-01-29 | 1996-03-27 | Merck Sharp & Dohme | Therapeutic agents |
US5773475A (en) * | 1997-03-17 | 1998-06-30 | Research Corporation Technologies, Inc. | Anticonvulsant enantiomeric amino acid derivatives |
US6277825B1 (en) * | 1996-07-22 | 2001-08-21 | University Of Utah Research Foundation | Use of conantokins for treating pain |
DK0934061T6 (en) * | 1996-07-24 | 2015-01-26 | Warner Lambert Co | Isobutylgaba and its derivatives for the treatment of pain |
US6589994B1 (en) | 1996-08-30 | 2003-07-08 | Nps Pharmaceuticals, Inc. | Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound |
US6048899A (en) * | 1997-03-17 | 2000-04-11 | Research Corporation Tech., Inc. | Anticonvulsant enantiomeric amino acid derivatives |
EP0997147B1 (en) | 1997-07-08 | 2006-03-15 | Ono Pharmaceutical Co., Ltd. | Amino acid derivatives |
WO1999003460A1 (en) * | 1997-07-15 | 1999-01-28 | Research Corporation Technologies, Inc. | Amino acid derivatives useful to treat stroke |
US6737408B1 (en) * | 1997-08-07 | 2004-05-18 | University Of Cincinnati | Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm |
WO1999007413A1 (en) | 1997-08-11 | 1999-02-18 | Algos Pharmaceutical Corporation | Substance p inhibitors in combination with nmda-blockers for treating pain |
US6492553B1 (en) * | 1998-01-29 | 2002-12-10 | Aventis Pharamaceuticals Inc. | Methods for preparing N-[(aliphatic or aromatic)carbonyl)]-2-aminoaetamide compounds and for cyclizing such compounds |
US6673832B1 (en) | 1998-05-04 | 2004-01-06 | Gudarz Davar | Methods for identifying compounds for treating pain |
GB9816228D0 (en) | 1998-07-24 | 1998-09-23 | Pfizer Ltd | Isoquinolines |
DE69908626T2 (en) * | 1998-10-09 | 2004-05-13 | Novartis Ag | ORAL COMBINATION OF LUFENURON AND NITENPYRAM AGAINST FLAE |
EP1121111B1 (en) | 1998-10-15 | 2010-02-10 | Imperial Innovations Limited | Compounds for the treatment of weight loss |
HUP0201402A3 (en) | 1999-09-03 | 2003-12-29 | Actelion Pharmaceuticals Ltd | Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them |
SE0001373D0 (en) | 2000-04-13 | 2000-04-13 | Karolinska Innovations Ab | NPY Y1 receptor agonists and antagonists |
CA2348847A1 (en) | 2000-05-31 | 2001-11-30 | Pfizer Inc. | New isoxazole-sulfonamide endothelin antagonists |
ES2245377T3 (en) * | 2000-08-17 | 2006-01-01 | Teva Pharmaceutical Industries Ltd. | USE OF DERIVATIVES OF AMIDAS OF VALPROIC ACID AND AMIDAS OF 2-VALPROENIC ACID FOR THE TREATMENT OR PREVENTION OF PAIN AND / OR HEADACHE DISORDERS. |
DE10041478A1 (en) | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | New pharmaceutical composition |
EP1695703B1 (en) * | 2000-08-25 | 2010-08-11 | Research Corporation Technologies, Inc. | Anticonvulsant amino acids for the treatment of obsessive-compulsive neurosis |
US6821978B2 (en) * | 2000-09-19 | 2004-11-23 | Schering Corporation | Xanthine phosphodiesterase V inhibitors |
ATE397584T1 (en) | 2000-11-21 | 2008-06-15 | Ucb Pharma Sa | N-ALKYLATED GABA COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS |
EG26979A (en) | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
CA2434495A1 (en) | 2001-01-30 | 2002-08-08 | Merck & Co., Inc. | Ophthalmic compositions for treating ocular hypertension |
DK1243262T3 (en) * | 2001-03-20 | 2006-10-02 | Sanol Arznei Schwarz Gmbh | Hitherto unknown use of a peptide class of compounds to treat non-neuropathic inflammatory pain |
ATE228358T1 (en) * | 2001-03-21 | 2002-12-15 | Sanol Arznei Schwarz Gmbh | NEW USE OF A CLASS OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF ALLODYNIA OR OTHER TYPES OF CHRONIC OR PHANTOMATIC PAIN |
KR20040016844A (en) | 2001-03-27 | 2004-02-25 | 액테리온 파마슈티칼 리미티드 | 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ⅱ receptors antagonists |
ITMI20011308A1 (en) | 2001-06-21 | 2002-12-21 | Nicox Sa | DRUGS FOR CHRONIC PAIN |
FR2831820B1 (en) | 2001-11-05 | 2004-08-20 | Ethypharm Sa | ORODISPERSIBLE TABLET HAVING HIGH HOMOGENEITY AND PREPARATION METHOD THEREOF |
WO2003099338A2 (en) * | 2002-05-17 | 2003-12-04 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
JP2006514110A (en) | 2002-11-11 | 2006-04-27 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | Phenyl or heteroarylaminoalkane derivatives as IP receptor antagonists |
US7687080B2 (en) * | 2002-11-25 | 2010-03-30 | Taraxos Inc. | Treatment of neuropathy |
US20040209960A1 (en) | 2003-01-30 | 2004-10-21 | Dynogen Pharmaceuticals, Inc. | Methods of treating lower urinary tract disorders using sodium channell modulators |
AU2004207009A1 (en) | 2003-01-30 | 2004-08-12 | Dynogen Pharmaceuticals, Inc. | Use of sodium channel modulators for treating gastrointestinal tract disorders |
US20040266743A1 (en) | 2003-05-09 | 2004-12-30 | Pharmacia Corporation | Combination of an aldosterone receptor antagonist and a renin inhibitor |
JP2007527412A (en) | 2003-10-24 | 2007-09-27 | エグゼリクシス, インコーポレイテッド | TAO kinase modulator and methods of use |
EP1537862A1 (en) | 2003-12-02 | 2005-06-08 | Schwarz Pharma Ag | Novel use of peptide compounds for treating central neuropathic pain |
JP4664924B2 (en) | 2003-12-02 | 2011-04-06 | ウーツェーベー ファルマ ゲーエムベーハー | Novel use of peptide compounds for the treatment of central neuropathic pain |
US20060009384A1 (en) * | 2003-12-05 | 2006-01-12 | David Rudd | Novel use of peptide compounds for treating status epilepticus or related conditions |
EP1541138A1 (en) | 2003-12-05 | 2005-06-15 | Schwarz Pharma Ag | Novel use of peptide compounds for treating status epilepticus or related conditions |
US20070042969A1 (en) * | 2004-03-26 | 2007-02-22 | Srz Properties, Inc. | Combination therapy for pain in painful diabetic neuropathy |
EP1579858A1 (en) | 2004-03-26 | 2005-09-28 | Schwarz Pharma Ag | Novel use of peptide compounds for treating pain in painful diabetic neuropathy |
US20050227961A1 (en) * | 2004-04-08 | 2005-10-13 | Vela Pharmaceuticals, Inc. | Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome |
CN1950101B (en) * | 2004-04-16 | 2011-03-30 | 舒沃茨药物股份公司 | Use of peptidic compounds for the prophylaxis and treatment of chronic headache |
EP1604654A1 (en) * | 2004-05-18 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating dyskinesia |
EP1604655A1 (en) * | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating pain in trigeminal neuralgia |
EP1604656A1 (en) * | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS) |
US7427601B2 (en) * | 2004-06-24 | 2008-09-23 | Schwarz Pharma Ag | Method for treating tremor |
CA2573125A1 (en) * | 2004-08-27 | 2006-03-02 | Schwarz Pharma Ag | Novel use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain |
EP1642889A1 (en) * | 2004-10-02 | 2006-04-05 | Schwarz Pharma Ag | Improved synthesis scheme for lacosamide |
US20060252749A1 (en) * | 2005-01-28 | 2006-11-09 | Srz Properties, Inc. | Lacosamide for add-on therapy of psychosis |
EP1688137A1 (en) | 2005-01-28 | 2006-08-09 | Schwarz Pharma Ag | SPM 927 for add-on therapy of schizophrenia |
EP1754476A1 (en) * | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia |
US20070043120A1 (en) * | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
US20070048372A1 (en) * | 2005-08-18 | 2007-03-01 | Srz Properties, Inc. | Method for treating non-inflammatory osteoarthritic pain |
-
2004
- 2004-12-02 JP JP2006541902A patent/JP4664924B2/en not_active Expired - Fee Related
- 2004-12-02 CA CA002545543A patent/CA2545543A1/en not_active Abandoned
- 2004-12-02 BR BRPI0417101-2A patent/BRPI0417101A/en not_active IP Right Cessation
- 2004-12-02 NZ NZ546576A patent/NZ546576A/en unknown
- 2004-12-02 EP EP04803465A patent/EP1689378B1/en active Active
- 2004-12-02 ES ES04803465T patent/ES2325995T3/en active Active
- 2004-12-02 DE DE602004020657T patent/DE602004020657D1/en active Active
- 2004-12-02 PL PL04803465T patent/PL1689378T3/en unknown
- 2004-12-02 AU AU2004294714A patent/AU2004294714B2/en not_active Ceased
- 2004-12-02 AT AT04803465T patent/ATE428413T1/en not_active IP Right Cessation
- 2004-12-02 KR KR1020067010051A patent/KR20060111524A/en not_active Application Discontinuation
- 2004-12-02 US US11/000,951 patent/US7794987B2/en not_active Expired - Fee Related
- 2004-12-02 EA EA200601074A patent/EA013590B1/en not_active IP Right Cessation
- 2004-12-02 WO PCT/EP2004/013729 patent/WO2005053667A1/en active Application Filing
-
2006
- 2006-05-18 IL IL175770A patent/IL175770A0/en unknown
- 2006-06-30 NO NO20063064A patent/NO20063064L/en not_active Application Discontinuation
-
2007
- 2007-03-20 HK HK07102954.3A patent/HK1095749A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1689378A1 (en) | 2006-08-16 |
CA2545543A1 (en) | 2005-06-16 |
PL1689378T3 (en) | 2009-09-30 |
HK1095749A1 (en) | 2007-05-18 |
US20050209163A1 (en) | 2005-09-22 |
KR20060111524A (en) | 2006-10-27 |
WO2005053667A1 (en) | 2005-06-16 |
JP4664924B2 (en) | 2011-04-06 |
EA013590B1 (en) | 2010-06-30 |
AU2004294714B2 (en) | 2009-12-10 |
DE602004020657D1 (en) | 2009-05-28 |
BRPI0417101A (en) | 2007-02-06 |
US7794987B2 (en) | 2010-09-14 |
IL175770A0 (en) | 2006-09-05 |
JP2007513119A (en) | 2007-05-24 |
NZ546576A (en) | 2009-05-31 |
EA200601074A1 (en) | 2006-10-27 |
NO20063064L (en) | 2006-09-01 |
ES2325995T3 (en) | 2009-09-28 |
EP1689378B1 (en) | 2009-04-15 |
AU2004294714A1 (en) | 2005-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE428413T1 (en) | NEW USE OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF CENTRAL NEUROPATHIC PAIN | |
ATE453653T1 (en) | PLATINUM COMPLEXES FOR THE TREATMENT OF TUMORS | |
DE50009504D1 (en) | USE OF RETIGABIN FOR THE TREATMENT OF NEUROPATHIC PAIN | |
DE60325770D1 (en) | USE OF RIMEXOLONE FOR THE TREATMENT OF EYE DRYNESS | |
DE60114580D1 (en) | USE OF CYANOCHINOLINES FOR THE TREATMENT OR INHIBITION OF THICK DARMPOLYPES | |
ATE518532T1 (en) | NEW USE OF A PEPTIDE CLASS OF COMPOUNDS FOR THE TREATMENT OF DIABETIC NEUROPATHIC PAIN | |
ATE410430T1 (en) | 2,3-DIHYDRO-6-NITROIMIDAZOÄ2,1-BUOXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | |
ATE494884T1 (en) | OXIDATIVE COMPOSITION FOR THE TREATMENT OF KERATIN FIBERS CONTAINING SPECIAL AMINO SILICONES | |
DE602005021970D1 (en) | USE OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF PAIN BY BONE CANCER, CHEMOTHERAPY AND NUCLEOSIDE-RELATED PAIN | |
DE60136477D1 (en) | RETINOIDES FOR THE TREATMENT OF EMPHYSEM | |
DE60130661D1 (en) | USE OF 13-CIS RETINIC ACID FOR THE TREATMENT OF EMPHYSEMES | |
ATE493125T1 (en) | CARBAMAT COMPOUNDS FOR TREATING PAIN | |
ATE302002T1 (en) | USE OF PYRAZOLE DERIVATIVES TO TREAT INFERTILITY | |
DE60214355D1 (en) | EXEMESTAN FOR THE TREATMENT OF HORMONE-RELATED DISORDER | |
ATE312104T1 (en) | COMPOUNDS FOR THE TREATMENT OF IMPAIRED FUNDIC RELAXATION | |
DE60213365D1 (en) | USE OF MGLUR5 ANTAGONISTS FOR THE TREATMENT OF PRITICAL CONDITIONS | |
DE60223707D1 (en) | CALCIUM-L-THREONATE FOR THE TREATMENT OF BONE FRACTURES | |
ATE549026T1 (en) | USE OF PINITOL FOR THE TREATMENT OF LIVER DISEASE IN MAMMALS | |
UA87117C2 (en) | Use of peptide compounds for treatment of central neuropatic pain | |
ATE506947T1 (en) | CONDENSED THIOPHENE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CHRONIC PAIN | |
DE60229047D1 (en) | SINGLE DOSE AROMATASE INHIBITORS FOR THE TREATMENT OF BARRENESS | |
DE60219495D1 (en) | Use of Interleukin-18 for the treatment of UV-associated skin diseases | |
DE10193322D2 (en) | Use of proton pump inhibitors for the treatment of diseases of the musculoskeletal system | |
DE60326348D1 (en) | MACROCLES FOR THE TREATMENT OF CANCER DISORDERS | |
DE602004003251D1 (en) | USE OF INDAZOL DERIVATIVES FOR THE TREATMENT OF NEUROPATHIC PAIN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |